Janux Therapeutics (JANX) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.51
-0.38
-0.24
-0.11

Details

Expected EPS
-0.382068
Actual EPS
-0.38
Surprise EPS
0
Surprise Percent
+0.54%

Description

Janux Therapeutics (JANX) has reported earnings of -0.38 per share for Q2 2025.

0 Comments

Share your thoughts